Loading…
Loading…
EQUITY / NASDAQ · XNCM
Cardio Diagnostics Holdings, Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗1.9 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 1.9 USD · Volume 33,536
251 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Cash and cash equivalents | 0 USD | — | — |
| Net income | -1,501,468 USD | -1,683,199 USD | — |
| Operating profit | -1,498,147 USD | -1,678,699 USD | — |
| Revenue | 5,360 USD | 7,475 USD | -28.29% |
| Total assets | 7,926,063 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 0 USD | — | — | 0 USD | 0 USD | 0 USD | — | — |
| Net incomeIncome statement | -1,501,468 USD | -3,289,626 USD | -1,788,158 USD | — | -6,498,167 USD | -1,714,536 USD | -5,032,799 USD | -1,683,199 USD |
| Operating profitIncome statement | -1,498,147 USD | -3,282,984 USD | — | — | -6,484,078 USD | -1,711,597 USD | -5,020,856 USD | -1,678,699 USD |
| RevenueIncome statement | 5,360 USD | 8,040 USD | — | — | 14,825 USD | 2,855 USD | 11,270 USD | 7,475 USD |
| Total assetsBalance sheet | 7,926,063 USD | — | — | 7,766,415 USD | 7,766,415 USD | 8,788,902 USD | — | — |
| Total equityBalance sheet | 7,426,283 USD | — | 8,903,399 USD | 6,973,354 USD | 6,973,354 USD | 8,151,571 USD | — | 9,724,699 USD |
| Total liabilitiesBalance sheet | 499,780 USD | — | — | 793,061 USD | 793,061 USD | 637,331 USD | — | — |
| Capital expendituresCash flow statement | — | 1,760 USD | — | — | 187,317 USD | — | 187,317 USD | — |
| Financing cash flowCash flow statement | — | 3,491,128 USD | — | — | 3,429,286 USD | — | 3,233,666 USD | — |
| Investing cash flowCash flow statement | — | -110,485 USD | — | — | -419,310 USD | — | -340,951 USD | — |
| Operating cash flowCash flow statement | — | -2,904,576 USD | — | — | -5,726,833 USD | — | -4,364,984 USD | — |
| Report source | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 03/13/2026 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 08/07/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.